The Clinical Characteristics and Prognosis of Patients With Anthracycline-Induced Cardiomyopathy

被引：0
|
作者：
Thomas, Garry R.
Siu, Vince
McDonald, Michael A.
Ross, Heather J.
Delgado, Diego H.
Billia, Filio
Rao, Vivek
Amir, Eitan
Thavendiranathan, Paaladinesh
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Cardiomyopathy; Ventricular function; Heart failure; adult; Cardiooncology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18687
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Mechanisms for anthracycline-induced cardiomyopathy: clinical and laboratory correlations
    Boucek, RJ
    PROGRESS IN PEDIATRIC CARDIOLOGY, 1997, 8 (02) : 59 - 70
  • [2] Anthracycline-induced cardiomyopathy
    Fisher, NG
    Marshall, AJ
    POSTGRADUATE MEDICAL JOURNAL, 1999, 75 (883) : 265 - 268
  • [3] Anthracycline-Induced Cardiomyopathy
    Simmons, Ashley
    Vacek, James L.
    Meyers, David
    POSTGRADUATE MEDICINE, 2008, 120 (04) : 67 - 72
  • [4] Pharmacologic Prevention of Anthracycline-Induced Cardiomyopathy
    Maradia, Kuldeep
    Guglin, Maya
    CARDIOLOGY IN REVIEW, 2009, 17 (05) : 243 - 252
  • [5] Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy
    Patel, Divyang
    Kumar, Anirudh
    Moennich, Laurie Ann
    Trulock, Kevin
    Nemer, David M.
    Donnellan, Eoin
    Il'Giovine, Zachary J.
    Martyn, Trejeeve
    Callahan, Thomas D.
    Hussein, Ayman A.
    Tarakji, Khaldoun G.
    Kanj, Mohamed
    Cantillon, Daniel J.
    Baranowski, Bryan
    Starling, Randall C.
    Tang, W. H. Wilson
    Wazni, Oussama M.
    Varma, Niraj
    Wilkoff, Bruce L.
    Rickard, John
    HEART, 2022, 108 (04) : 274 - 278
  • [6] Anthracycline-Induced Cardiomyopathy Clinical Relevance and Response to Pharmacologic Therapy
    Cardinale, Daniela
    Colombo, Alessandro
    Lamantia, Giuseppina
    Colombo, Nicola
    Civelli, Maurizio
    De Giacomi, Gaia
    Rubino, Mara
    Veglia, Fabrizio
    Fiorentini, Cesare
    Cipolla, Carlo M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (03) : 213 - 220
  • [7] Anthracycline-induced cardiomyopathy: secrets and lies
    Farmakis, Dimitrios
    Mantzourani, Marina
    Filippatos, Gerasimos
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (05) : 907 - 909
  • [8] Protective effects of spironolactone against anthracycline-induced cardiomyopathy
    Akpek, Mahmut
    Ozdogru, Ibrahim
    Sahin, Omer
    Inanc, Mevlude
    Dogan, Ali
    Yazici, Cevat
    Berk, Veli
    Karaca, Halit
    Kalay, Nihat
    Oguzhan, Abdurrahman
    Ergin, Ali
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) : 81 - 89
  • [9] The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition
    Berkman, Amy M.
    Hildebrandt, Michelle A. T.
    Landstrom, Andrew P.
    CLINICAL GENETICS, 2021, 100 (02) : 132 - 143
  • [10] Is Bilirubin Protective Against Anthracycline-induced Cardiomyopathy?
    Vera, Trinity
    Morgan, Timothy M.
    Jordan, Jennifer H.
    Whitlock, Matthew C.
    Kitzman, Dalane
    Hundley, W. G.
    CIRCULATION, 2014, 130
12345